Cargando…

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer

OBJECTIVE: Cytoreductive radical prostatectomy (cRP) has been proposed as local treatment option in metastatic hormone-sensitive prostate cancer (mHSPC) to prevent local complications and potentially improve oncological outcomes. In this study, we examined the feasibility of a multimodal concept wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babst, Christa, Amiel, Thomas, Maurer, Tobias, Knipper, Sophie, Lunger, Lukas, Tauber, Robert, Retz, Margitta, Herkommer, Kathleen, Eiber, Matthias, von Amsberg, Gunhild, Graefen, Markus, Gschwend, Juergen, Steuber, Thomas, Heck, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Second Military Medical University 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841247/ https://www.ncbi.nlm.nih.gov/pubmed/35198399 http://dx.doi.org/10.1016/j.ajur.2021.04.003

Ejemplares similares

Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
por: Knipper, Sophie, et al.
Publicado: (2021)

Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer
por: Lunger, Lukas, et al.
Publicado: (2021)

Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
por: Falkenbach, Fabian, et al.
Publicado: (2023)

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy
por: Lunger, Lukas, et al.
Publicado: (2020)

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer
por: Thalgott, Mark, et al.
Publicado: (2014)

Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients
por: Heck, Matthias M., et al.
Publicado: (2013)

[(11)C]Choline PET/CT in therapy response assessment of a neoadjuvant therapy in locally advanced and high risk prostate cancer before radical prostatectomy
por: Schwarzenböck, Sarah M., et al.
Publicado: (2016)

Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy
por: Lunger, Lukas, et al.
Publicado: (2023)

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients
por: Thalgott, Mark, et al.
Publicado: (2015)

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
por: Sasaki, Takeshi, et al.
Publicado: (2021)

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Ge, Qingyu, et al.
Publicado: (2022)

Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer
por: Zhang, Peng, et al.
Publicado: (2022)

PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer
por: Ambrosini, Francesca, et al.
Publicado: (2023)

Does experience change the role of systematic biopsy during MRI-fusion biopsy of the prostate?
por: Jahnen, Matthias, et al.
Publicado: (2023)

Primary Tumor Treatment in Oligometastatic Prostate Cancer: Radiotherapy Versus Radical Prostatectomy
por: Knipper, Sophie, et al.
Publicado: (2022)

Changing nationwide trends away from overtreatment among patients undergoing radical prostatectomy over the past 25 years
por: Meissner, Valentin H., et al.
Publicado: (2023)

PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
por: Wang, Hui, et al.
Publicado: (2021)

Combination Chemohormonal Therapy in Metastatic Salivary Duct Carcinoma
por: Jeong, Il Seok Daniel, et al.
Publicado: (2020)

Current Staging Procedures in Urinary Bladder Cancer
por: Maurer, Tobias, et al.
Publicado: (2013)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023)

Diversity of cancer-related identities in long-term prostate cancer survivors after radical prostatectomy
por: Jahnen, Matthias, et al.
Publicado: (2021)

Benefit finding in men affected by prostate cancer prior to and following radical prostatectomy – a cross-sectional study with a stratified sample
por: Jahnen, Matthias, et al.
Publicado: (2023)

Both radiographical and pathological lymph node statuses are independent predictors for survival following neoadjuvant chemotherapy and radical cystectomy for cT3/4 or cN+ bladder cancer
por: Wagner, Julia, et al.
Publicado: (2022)

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
por: Oishi, Takuya, et al.
Publicado: (2023)

Emerging role of cytoreductive prostatectomy in patients with metastatic disease
por: Jaber, Yasmeen, et al.
Publicado: (2018)

Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance
por: Meissner, Valentin H., et al.
Publicado: (2021)

S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer
por: Nawroth, Roman, et al.
Publicado: (2011)

Prostate cancer‐related anxiety among long‐term survivors after radical prostatectomy: A longitudinal study
por: Meissner, Valentin H., et al.
Publicado: (2022)

Association between masturbation and functional outcome in the postoperative course after nerve-sparing radical prostatectomy
por: Meissner, Valentin H., et al.
Publicado: (2020)

The role of fatal family history and mode of inheritance in prostate cancer for long-term outcomes following radical prostatectomy
por: Meissner, Valentin H., et al.
Publicado: (2020)

Cytoreductive prostatectomy: Evidence in support of a new surgical paradigm (Review)
por: FAIENA, IZAK, et al.
Publicado: (2014)

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study
por: Kim, Dae Keun, et al.
Publicado: (2018)

AB056. Cytoreductive radical prostatectomy for men with oligo-metastatic prostate cancer
por: Liu, Shengjie, et al.
Publicado: (2017)

Cytoreductive robot‐assisted prostatectomy for systemic prostate rhabdomyosarcoma presenting as urinary retention
por: Kirisawa, Takahiro, et al.
Publicado: (2021)

AB0/Rhesus Blood Group Does Not Influence Clinicopathological Tumor Characteristics or Oncological Outcome in Patients Undergoing Radical Prostatectomy
por: Oh, Su Jung, et al.
Publicado: (2017)

Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer
por: Aguiar, Pedro Nazareth, et al.
Publicado: (2017)

Results of Phase 1 study on cytoreductive radical prostatectomy in men with newly diagnosed metastatic prostate cancer
por: Yuh, Bertram E., et al.
Publicado: (2019)

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer
por: Narita, Shintaro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0jh4og3c7kgcfaboj7026reuhi